SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-037250
Filing Date
2020-08-06
Accepted
2020-08-06 07:30:32
Documents
14
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION atrs-8k_20200806.htm   iXBRL 8-K 40711
2 EX-99.1 PRESS RELEASE atrs-ex991_6.htm EX-99.1 355109
3 GRAPHIC gbf3jx3kteou000001.jpg GRAPHIC 17898
  Complete submission text file 0001564590-20-037250.txt   568807

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atrs-20200806.xsd EX-101.SCH 5796
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20200806_lab.xml EX-101.LAB 19478
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20200806_pre.xml EX-101.PRE 11645
7 EXTRACTED XBRL INSTANCE DOCUMENT atrs-8k_20200806_htm.xml XML 3549
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 201079826
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences